Prostate artery embolization for benign prostatic hyperplasia: a retrospective single-center study of clinical outcome

Objective: To evaluate clinical outcome and complications of prostate artery embolization (PAE) in Iceland, using the International Prostate Symptom Score (IPSS), quality of life (QoL) and catheter freedom to measure clinical success. Materials and methods: Retrospective single-center study, incl...

Full description

Saved in:
Bibliographic Details
Main Authors: Jon Bjarnason, Johann Pall Ingimarsson, Hjalti Thorisson, Kristbjorn Reynisson, Jon Orn Fridriksson, Baldvin Thorkell Kristjansson, Fernando Bazan
Format: Article
Language:English
Published: Medical journals sweden AB 2025-07-01
Series:Scandinavian Journal of Urology
Subjects:
Online Access:https://medicaljournalssweden.se/SJU/article/view/44137
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective: To evaluate clinical outcome and complications of prostate artery embolization (PAE) in Iceland, using the International Prostate Symptom Score (IPSS), quality of life (QoL) and catheter freedom to measure clinical success. Materials and methods: Retrospective single-center study, including patients who underwent PAE from August 2019 to February 2024 due to benign prostatic hyperplasia (BPH). Patients completed a questionnaire on lower urinary tract symptoms (LUTS), QoL, catheter status and use of medication. All additional data were retrieved from the medical records.  Results: A total of 34 patients were included, with a mean age of 75 during PAE and a technical success rate of 91%. Patients had significant clinical improvement, with a mean reduction in IPSS score from 20.0 to 9.0 (p < 0.001) and QoL score from 5.5 to 1.8 (p < 0.001). PAE also resulted in a 69% reduction (p < 0.001) in urinary catheter dependency. Post-PAE complications were uncommon (3/34) and all resolved without long-term effects. Conclusion: PAE is an effective and safe treatment option for LUTS and/or urinary retention in men with BPH, offering catheter freedom and significant improvement in urological symptoms and quality of life.
ISSN:2168-1813